✨ Key Finding: Current evidence does not support an early AVR strategy for moderate AS in patients with HFrEF, as TAVI has not shown prognostic benefits in this group.
✨ Key Finding: The use of a wearable cardioverter-defibrillator resulted in a 1% delivery rate of appropriate shocks in patients with non-ischaemic cardiomyopathy, indicating a significant risk of life-threatening ventricular arrhythmias during the medical optimization period.
✨ Key Finding: Intravascular ultrasound revealed a large intraluminal thrombus without plaque in a patient with septic coronary embolism, leading to avoidance of stent implantation.
Based on your interests and feeds
✨ Key Finding: Cardiac MRI showed near-complete resolution of late gadolinium enhancement and improved LVEF from 44.6% to 49% at 6 months in a patient with Shigella-associated myocarditis.
✨ Key Finding: Sarcomeric hypertrophic cardiomyopathy is linked to a worse prognosis, necessitating vigilant surveillance and lower thresholds for advanced therapies.
✨ Key Finding: PRMT3-mediated arginine methylation stabilizes PCSK9, promoting aortic valve calcification in valve interstitial cells during calcific aortic valve disease.
✨ Key Finding: YAP induces a prorenewal metabolic state in cardiomyocytes, enhancing their potential for proliferation and heart regeneration.
✨ Key Finding: A change from cardiac fibroblasts to cardiac myofibroblasts in the right ventricle is a driver of decompensation in pulmonary arterial hypertension.
Umbrella review synthesizes the impact of wrist-worn wearables on health outcomes, indicating varied benefits in adults with health conditions.
Dynamic changes in plaque vulnerability indicators in carotid arteries suggest potential assessments using MR imaging.